Kerala Ayurveda Limited (BOM:530163)
India
· Delayed Price · Currency is INR 196.70
-16.20 (-7.61%)
At close: Mar 9, 2026
Kerala Ayurveda Revenue
Kerala Ayurveda had revenue of 329.59M INR in the quarter ending December 31, 2025, with 5.88% growth. This brings the company's revenue in the last twelve months to 1.27B, up 1.00% year-over-year. In the fiscal year ending March 31, 2025, Kerala Ayurveda had annual revenue of 1.20B with 16.32% growth.
Revenue (ttm)
1.27B
Revenue Growth
+1.00%
P/S Ratio
1.86
Revenue / Employee
3.47M
Employees
367
Market Cap
2.37B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 1.20B | 168.35M | 16.32% |
| Mar 31, 2024 | 1.03B | 95.06M | 10.15% |
| Mar 31, 2023 | 936.23M | 131.79M | 16.38% |
| Mar 31, 2022 | 804.44M | 183.70M | 29.59% |
| Mar 31, 2021 | 620.74M | -146.99M | -19.15% |
| Mar 31, 2020 | Pro | Pro | Pro |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2018 | Pro | Pro | Pro |
| Mar 31, 2017 | Pro | Pro | Pro |
| Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sat Kartar Life | 1.63B |
| Gennex Laboratories | 1.52B |
| Everest Organics | 1.89B |
| BDH Industries | 847.44M |
| Sanjivani Paranteral | 736.34M |
| Trident Lifeline | 1.27B |
| ZIM Laboratories | 3.78B |
| Ambalal Sarabhai Enterprises | 2.03B |